YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes

Hormone and Metabolic Research

Volumn 30, Issue 9, 1998, Pages 543-548

  Shimaya, A ^a   Kurosaki, E ^a   Shioduka, K ^b   Nakano, R ^a   Shibasaki, M ^a   Shikama, H ^a,b  

^a Astellas Pharma   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

2 Deoxyglucose; Activated Receptor ; Insulin; Insulin Sensitizer; Peroxisome Proliferator; Phospatidylinositol 3 Kinase; Phosphatidylinositol 3,4,5 Trisphosphate; Pioglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BIS[4 [(2,4 DIOXO 5 THIAZOLIDINYL)METHYL]PHENYL]METHANE; DEOXYGLUCOSE; FATTY ACID BINDING PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHOLIPID; PIG INSULIN; PIOGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; SUS SCROFA;

EID: 0031720840     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978929     Document Type: Article

References (38)

1. Olefsky JM. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes 1981; 30: 148-62
2. Obermaier-Kusser B, White MF, Pongratz DE, Su Z, Ermel B, Muhlbacher C, Haring HU. A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. J Biol Chem 1989; 264: 9497-504
3. Grunberger G, Zick Y, Gorden P. Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient with normal insulin binding. Science 1984; 223: 932-4
4. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 1988; 37: 1549-58
5. Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneim Forsch 1990; 40: 156-62
6. Hayakawa T, Shiraki T, Morimoto T, Shii K, Ikeda H. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats. Biochem Biophys Res Commun 1996; 223: 439-44
7. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kleiwer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAPγ). J Biol Chem 1995; 270: 12953-6
8. Kletzien RF, Clarke SD, Ulrich RG. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol 1992; 41: 393-8
9. Hofmann C, Lorenz K, Colca JR. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. Endocrinology 1991; 129: 1915-25
10. Folli F, Saad MJA, Backer JM, Kahn CR. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal model of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 1993; 92: 1787-94
11. Heydrick S, Jullien D, Gautier N, Tanti JF, Giorgetti S, von Obberghen E, Le Marchand-Brustel Y. Defect in skeletal muscle phosphatidylinositol 3-kinase in obese insulin-resistant mice. J Clin Invest 1993; 91: 1358-66
12. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J Biol Chem 1994; 269: 3568-73
13. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 1994; 14: 4902-11
14. Zhang B, Szalkowski D, Diaz E, Hayes N, Smith R, Berger J. Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. J Biol Chem 1994; 269: 25735-41
15. Noshiro O, Hirayama R, Shimaya A, Yoneta T, Niigata K, Shikama H. Role of plasma insulin concentration in regulating glucose and lipid metabolism in lean and obese Zucker rats. Int J Obesity 1997; 21: 115-21
16. Shimaya A, Noshiro O, Hirayama R, Yoneta T, Niigata K, Shikama H. Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased contents of GLUT4 in adipose tissue of obese Zucker rats. Eur J Endocrinol 1997; 137: 693-700
17. van Putten JPM, Wieringa T, Krans HMJ. Long-term regulation of hexose transport by insulin in cultered mouse (3T3) adipocytes. Diabetologia 1985; 28: 51-6
18. Bernlohr DA, Angus CW, Lane MD, Bolanowski MA, Kelly TJ Jr. Expression of specific mRNAs during adipose differentiation: Identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci USA 1984; 81: 5468-72
19. Shimokawa T, Kawabe Y, Honda M, Yazaki Y, Matsumoto A, Itakura H, Kodama T. Determination of mRNA levels of cholesterol biosynthesis enzyme and LDL receptor using ribonuclease protection assay. J Lipid Res 1995; 36: 1919-24
20. Ezaki O, Flores-Riveros JR, Kastener KH, Gearhart J, Lane MD. Regulated expression of an insulin-responsive glucose transporter (GLUT4) minigine in 3T3-L1 adipocytes and transgenic mice. Proc Natl Acad Sci USA 1993; 90: 3348-52
21. Shimokawa T, Kato M, Shioduka K, Irie J, Ezaki O. Effect of triiodothyronine on muscle cell differentiation and blood glucose level in hyperglycemic kk mice. Biochem Biophys Res Commun 1997; 235: 790-3
22. Robb JA, Huebner K. Effect of cell chromosome number on simian virus 40 replication. Exptl Cell Res 1973; 81: 120-6
23. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 1994; 91: 7355-9
24. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270: 1491-4
25. Matsuo T, Hazeki K, Hazeki O, Katada T, Ui M. Activation of phosphatidylinositol 3-kinase by concanavalin A through dual signaling pathways, G-protein-coupled and phosphotyrosine-related, and an essential role of the G-protein coupled signals for the lectin-induced respiratory burst in human monocytic THP-1 cells. Biochem J 1996; 315: 505-12
26. Traynor-Kaplan AE, Thompson BL, Harris AL, Taylor P, Omann GM, Sklar LA. Transient increase in phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol trisphosphate during activation of human neutrophils. J Biol Chem 1989; 264: 15668-73
27. Sargeant RJ, Pâquet MR. Effect of insulin on the rate of synthesis and degradation of GLUT1 and GLUT4 glucose transporters in 3T3-L1 adipocytes. Biochem J 1993; 290: 913-9
28. Flores-Riveros JR, McLenithan JC, Ezaki O, Lane MD. Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: Effects on transcription and mRNA turnover. Proc Natl Acad Sci USA 1993; 90: 512-6
29. Kozka IJ, Clark AE, Holman GD. Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes. J Biol Chem 1991; 266: 11726-31
30. Tafuri SR. Troglitazone enhances differentiation, basal glucose uptake, and GLUT1 protein levels in 3T3-L1 adipocytes. Endocrinology 1996; 137: 4706-12
31. Sandouk T, Reda D, Hofmann C. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 1993; 264: C1600-8
32. Sandouk T, Reda D, Hofmann C. The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology 1993; 133: 352-9
33. Kaestner KH, Christy RJ, McLenithan JC, Braiterman LT, Cornelius P, Pekala PH, Lane MD. Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes. Proc Natl Acad Sci USA 1989; 86: 3150-4
34. Clarke JF, Young PW, Yonezawa K, Kasuga M, Holman GD. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J 1994; 300: 631-5
35. Kanai F, Ito K, Todaka M, Hayashi H, Kamohara S, Ishii K, Okada T, Hazeki O, Ui M, Ebina Y. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of P13-kinase. Biochem Biophys Res Commun 1993; 195: 762-8
36. Sizer KM, Smith CL, Jacob CS, Swanson ML, Bleasdale JE. Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism. Mol Cell Endocrinol 1994; 103: 1-12
37. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91
38. Szalkowski D, White-Carrington S, Berger J, Zhang B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 1995; 136: 1474-81